BioGaia AB Class B

Biogaia AB's next confirmed earnings release is scheduled for February 12, 2027.

As of June 30, 2026, Biogaia AB has 100.80M shares outstanding.

As of June 30, 2026, Biogaia AB maintains a current ratio of 4.44, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Biogaia AB posted a return on equity (ROE) of 25.64, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 25.26 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 21.92, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 25.90, useful for judging operating efficiency across full business cycles. The company generates approximately 719,594.95 in revenue per employee across its workforce of 237.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Biogaia AB recorded 10.34M in income tax expense. That works out to an effective tax rate of 21.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 48.43M, leaving 38.09M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 24, 2026, Biogaia AB's stock has gained approximately 31.05% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Biogaia AB generated 171.08M in revenue and converted that into 38.09M in net income, yielding earnings per share of 0.38. EBITDA reached 50.24M, while operating income came in at 47.71M.

These figures are as of June 30, 2026. Total book value stands at 113.58M, with working capital of 75.19M providing operational flexibility.

Biogaia AB produced 29.07M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.58M in capital expenditures, free cash flow totaled 27.49M - equivalent to 0.27 per share.

Over the twelve months ended June 30, 2026, Biogaia AB posted a gross margin of 72.67, reflecting its pricing power and cost economics. The operating margin of 27.89 and net profit margin of 22.26 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Biogaia AB paid dividends of 1.13 per share. The dividend payout ratio of 298.62 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Biogaia AB's most recent stock split took place on May 26, 2022 with a 2:5 split ratio.